Quanterix Corp (QTRX)

$6.65 +0.08 (1.22%)
Market Cap 240.74M
Revenue (ttm) 137.42M
Net Income (ttm) -38.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.04%
Debt to Equity Ratio 0.00
Volume 1,424,700
Avg Vol 761,852
Day's Range N/A - N/A
Shares Out 38.83M
Stochastic %K 83%
Beta 1.05
Analysts Sell
Price Target $11.25

Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Sim...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 301 9400
Address:
Building 1, 900 Middlesex Turnpike, Billerica, United States
TheSleeeve
TheSleeeve Jun. 25 at 7:05 PM
$QTRX I see everyone suddenly added at 5.74. Lol!
0 · Reply
MGeronimo
MGeronimo Jun. 25 at 5:01 PM
$QTRX added at 5.74 let’s see a power hour upswing
0 · Reply
rangerhawkeye
rangerhawkeye Jun. 25 at 3:09 PM
$QTRX added 5.74 for a swing
0 · Reply
taotrader
taotrader Jun. 24 at 5:49 PM
$QTRX How can a stock be down 10% one day for no Damn Reason on an up day for stocks? This is ridiculous. What am I supposed to do. I am sure if I sell it will rebound. If I hold it will keep plummeting
1 · Reply
taotrader
taotrader Jun. 24 at 5:12 PM
$QTRX Why the hell is this getting killed today? Recent mass insider buying. Positive news yesterday. Up market. WTF WTF WTF WTF. I can not win anymore. 2nd stock this month that screws me like this when everything indicates it should be going up. Certianly not getting crushed for No God Damn Reason.
0 · Reply
Sami2021
Sami2021 Jun. 24 at 3:21 PM
$QTRX why is this crashing anybody know?
0 · Reply
MGeronimo
MGeronimo Jun. 20 at 10:09 PM
$QTRX 4.28 to 6.42 bam
0 · Reply
GSP
GSP Jun. 18 at 4:12 PM
This $QTRX chart is interesting. .
0 · Reply
Will2ride1
Will2ride1 Jun. 18 at 2:34 PM
$QTRX making it's way north 📈
0 · Reply
Will2ride1
Will2ride1 Jun. 16 at 11:40 PM
$QTRX Insider buying 👁
1 · Reply
Latest News on QTRX
Quanterix Expands Reach with IVD and Large Reference Labs

Jun 23, 2025, 7:30 AM EDT - 4 days ago

Quanterix Expands Reach with IVD and Large Reference Labs

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Jun 11, 2025, 8:00 AM EDT - 16 days ago

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Jun 6, 2025, 9:41 AM EDT - 21 days ago

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

May 23, 2025, 2:21 PM EDT - 5 weeks ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

AKYA

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 11:19 PM EDT - 6 weeks ago

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

Quanterix Releases Financial Results for the First Quarter of 2025

May 12, 2025, 4:01 PM EDT - 6 weeks ago

Quanterix Releases Financial Results for the First Quarter of 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

May 7, 2025, 3:46 PM EDT - 7 weeks ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

AKYA

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

May 5, 2025, 7:00 AM EDT - 7 weeks ago

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Apr 30, 2025, 8:00 AM EDT - 2 months ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

AKYA

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Apr 29, 2025, 7:00 AM EDT - 2 months ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

AKYA

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Apr 17, 2025, 8:30 AM EDT - 2 months ago

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

Apr 14, 2025, 8:00 AM EDT - 2 months ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

AKYA

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

Apr 7, 2025, 8:15 AM EDT - 2 months ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

AKYA

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Apr 1, 2025, 1:00 AM EDT - 3 months ago

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

Mar 24, 2025, 8:00 AM EDT - 3 months ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 7:19 PM EDT - 3 months ago

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Mar 17, 2025, 4:01 PM EDT - 3 months ago

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Mar 17, 2025, 4:00 PM EDT - 3 months ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

AKYA

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Mar 13, 2025, 1:00 PM EDT - 3 months ago

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

Mar 11, 2025, 8:00 AM EDT - 3 months ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Mar 3, 2025, 8:00 AM EST - 4 months ago

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Mar 3, 2025, 6:00 AM EST - 4 months ago

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Mar 2, 2025, 11:00 AM EST - 4 months ago

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Feb 19, 2025, 8:30 AM EST - 4 months ago

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

Feb 18, 2025, 3:40 PM EST - 4 months ago

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

AKYA

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Feb 14, 2025, 5:48 PM EST - 4 months ago

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Feb 5, 2025, 3:43 PM EST - 5 months ago

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

Feb 1, 2025, 11:00 AM EST - 5 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm

Jan 28, 2025, 9:00 PM EST - 5 months ago

Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm

TMDX

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud

Jan 28, 2025, 11:00 AM EST - 5 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud

Quanterix Provides Update on Financial Performance

Jan 14, 2025, 7:00 AM EST - 5 months ago

Quanterix Provides Update on Financial Performance

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

Jan 10, 2025, 7:00 AM EST - 6 months ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

AKYA

David R. Walt Receives National Medal of Technology and Innovation

Jan 6, 2025, 9:30 AM EST - 6 months ago

David R. Walt Receives National Medal of Technology and Innovation

Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:26 PM EST - 6 months ago

Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation For Securities Fraud

Dec 28, 2024, 1:15 PM EST - 6 months ago

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation For Securities Fraud

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

Dec 23, 2024, 10:45 AM EST - 6 months ago

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

Dec 20, 2024, 2:00 PM EST - 6 months ago

The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

Dec 18, 2024, 10:45 AM EST - 6 months ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud

Quanterix Expands Capabilities with Strategic Acquisition of EMISSION

Dec 17, 2024, 6:59 AM EST - 6 months ago

Quanterix Expands Capabilities with Strategic Acquisition of EMISSION

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation's Possible Securities Fraud

Dec 16, 2024, 10:45 AM EST - 6 months ago

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Quanterix Corporation's Possible Securities Fraud

TheSleeeve
TheSleeeve Jun. 25 at 7:05 PM
$QTRX I see everyone suddenly added at 5.74. Lol!
0 · Reply
MGeronimo
MGeronimo Jun. 25 at 5:01 PM
$QTRX added at 5.74 let’s see a power hour upswing
0 · Reply
rangerhawkeye
rangerhawkeye Jun. 25 at 3:09 PM
$QTRX added 5.74 for a swing
0 · Reply
taotrader
taotrader Jun. 24 at 5:49 PM
$QTRX How can a stock be down 10% one day for no Damn Reason on an up day for stocks? This is ridiculous. What am I supposed to do. I am sure if I sell it will rebound. If I hold it will keep plummeting
1 · Reply
taotrader
taotrader Jun. 24 at 5:12 PM
$QTRX Why the hell is this getting killed today? Recent mass insider buying. Positive news yesterday. Up market. WTF WTF WTF WTF. I can not win anymore. 2nd stock this month that screws me like this when everything indicates it should be going up. Certianly not getting crushed for No God Damn Reason.
0 · Reply
Sami2021
Sami2021 Jun. 24 at 3:21 PM
$QTRX why is this crashing anybody know?
0 · Reply
MGeronimo
MGeronimo Jun. 20 at 10:09 PM
$QTRX 4.28 to 6.42 bam
0 · Reply
GSP
GSP Jun. 18 at 4:12 PM
This $QTRX chart is interesting. .
0 · Reply
Will2ride1
Will2ride1 Jun. 18 at 2:34 PM
$QTRX making it's way north 📈
0 · Reply
Will2ride1
Will2ride1 Jun. 16 at 11:40 PM
$QTRX Insider buying 👁
1 · Reply
kshonstocks
kshonstocks Jun. 16 at 7:00 PM
Good insider buying on $QTRX http://openinsider.com/search?q=qtrx
0 · Reply
MGeronimo
MGeronimo Jun. 16 at 1:27 PM
$QTRX 700K in insider buying in at $6.36
0 · Reply
MGeronimo
MGeronimo Jun. 13 at 11:44 PM
$QTRX INSIDER BUYING AND DECENY FINANCIAL NUMBERS IN AT $6.06
0 · Reply
MGeronimo
MGeronimo Jun. 13 at 11:32 PM
$QTRX SOLID AFTER HOOURS AFTER PANIC SELLING BECAUSE OF IRAN
0 · Reply
BOS7
BOS7 Jun. 11 at 9:36 PM
$QTRX any blood based Alzheimer's testing PR could send this over 10. Insiders keep acquiring shares. Cost saving program aims to save $55M by 2026. Huge upside potential here.
0 · Reply
BOS7
BOS7 Jun. 11 at 8:13 PM
$QTRX 7 break on watch tomorrow
0 · Reply
MGeronimo
MGeronimo Jun. 11 at 3:28 PM
$QTRX $5.06 to $6.56 bam
0 · Reply
MGeronimo
MGeronimo Jun. 11 at 3:25 PM
$QTRX $4.99 to $6.81
1 · Reply
BOS7
BOS7 Jun. 11 at 1:50 PM
$QTRX insider scooping up. Swing idea. Pt: 10+
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 11 at 1:40 PM
$QTRX $7.03 high awesome overnighter for us. Nicely done if you're in🥇 🥇
0 · Reply
topstockalerts
topstockalerts Jun. 11 at 2:44 AM
Top Gainers PT2 $MEGL $WINT $QSG $KWM $QTRX
0 · Reply
MGeronimo
MGeronimo Jun. 11 at 1:23 AM
$QTRX $5 to $6.80
0 · Reply